drug
as of 2026-07-01Antipsychotic therapy
at a glance
small molecule
Pre-approval / investigational in the US
Developed by FORUM Pharmaceuticals Inc
1 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Trials
1
Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Schizophrenia
NCT01556763Phase 1Completed
KOLs & investigators
1
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
indication
indication
indication
indication
KOL
Sheldon H. Preskorn, M.D.
personKOL score —